Resource
Rondecabtagene Autoleucel, an Autologous, Dual-Targeting CD19/CD20 CAR T-Cell Candidate Manufactured from CD62L+ Enriched T Cells, Achieves Durable Responses in Patients with Large B-Cell Lymphoma
Publication Date: December 7, 2025
Source: ASH
Author(s): Sarah M. Larson, Umar Farooq, Tahir Latif, Felix Mensah, Bradley D. Hunter, Stefan O. Ciurea, Nebu Koshy, Locke Bryan, Boyu Hu, William Clark, Hassaan Yasin, Yeonhee Kim, Greg Kaufman, Akil Merchant
Resource Type: Presentation